ascenion
clear

All antibodies are monoclonals unless stated otherwise. To receive further information on an antibody of interest please contact Anja Zimmermann.

AB

CD

EF

GH

IJ

KL

MN

OP

QR

ST

UV

WZ

Antigen      

Fusion

Publication       

E1B AP5 / HNRPUL1, Ribonucleoprotein hnRNP

 EAP 

Kzhyshkowska, J. et al. Biochem. J. 358, 305-314 (2001)

EBV, BHRF1

 BHRF

Nicholls, J. et alJ. Med. Virol. 65, 105-113 (2001)

EBV, dUTPase 

 UTP-T            

Sommer, P. et al. J. Gen. Virol. 77, 2795-2805 (1996) / Fleischmann, J. et al. Int. J. Cancer 84, 614-617 (1999) / Fleischmann, J. et al. J. Med. Virol. 68, 568-573 (2002)

EBV, EBNA1

 E1-BS (EBNA1)

Grässer, F.A. et al. Blood 84, 3792-3798 (1994) / Murray, P.G. et al. J. Pathol., 178, 44-47 (1996) / Fischer, N. et al. J. Biol. Chem. 272, 3999-4005 (1997)

EBV, EBNA2, several epitopes

EBNA  Maus EBNA2

 

EBV, EBNA2, wwp-peptide

 WWP-K

Sauder, Ch. Et al. J. Gen. Virol. 77, 991-996 (1996)

EBV, EBNA2A, several epitopes

EBNA Ratte EBNA2

Sauder, Ch. Et al. J. Gen. Virol. 77, 991-996 (1996) /Kremmer, E. et al.  Virology 208, 336-342 (1995)

EBV, EBNA2b, several epitopes

E2B RATTE

Kremmer, E. et al. Virology 208, 336-342 (1995)

EBV, LMP1, several epitopes

 LMP

Nicholls J et al. J Virol Methods. 2004 Mar 1;116(1):79-88

EBV, LMP2a, TP, several epitopes

 TP

Niedobitek, G. et al. Blood 90, 1664-1672 (1997) / Fruehling, S. et al. J. Virol. 70, 6216-6226 (1996)

EDG

 MG

Gräler, M.H. et al. J. Cell. Biochem. 89, 507-519 (2003)

ENV, Herv K10

 ENV

 

ENV, Herv K10

 OM

 

ENV, Herv K10

 TM

 

Epitopes, several, HIV-2, Nef protein

 HOM

Fackler, O.T. et al. Eur. J. Biochem. 247, 843-851 (1997) / Fackler, O.T. et al. Virus Res. 46, 105-110 (1996)

Epsilon chain, Protein kinase C

 EPS

 

FC gamma receptor, mouse, blocking, several isotypes

 FCR

 

Formin-related protein in leukocytes 1

 

 

 FMNL1 

 

 

 

Blood, 2007, Jul 12, Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematological and other malignancies

FITC

FITC-R

 

FLT-1

 

FLT

Barleon, B. et al. J. Biol. Chem. 272, 10382-10388 (1997)

 

 

Kontakt:

Dr. Anja Zimmermann
Ascenion GmbH
T: +49 (0)89 318814-0
F: +49 (0)89 318814-20
zimmermann(at)ascenion.de